Equities

Vycor Medical Inc

VYCO:QBB

Vycor Medical Inc

Actions
  • Price (USD)0.093
  • Today's Change0.005 / 5.44%
  • Shares traded4.23k
  • 1 Year change+2.82%
  • Beta0.4504
Data delayed at least 15 minutes, as of Mar 28 2024 16:25 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vycor Medical, Inc. provides surgical and therapeutic solutions. The Company operates through two segments: Vycor Medical and NovaVision. The Company’s Vycor Medical segment designs, develops and markets medical devices for use in neurosurgery. NovaVision segment provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. The Company designs, develops and markets neurological medical devices and therapies. Vycor Medical's product Vycor Medical's ViewSite Brain Access System (VBAS) is a next generation retraction and access system. Vycor Medical focuses on brain and cervical surgical access systems for sale to hospitals and medical professionals. NovaVision's products include Vision Restoration Therapy (VRT), NeuroEyeCoach and Neuro-Eye Therapy (NeEt). The Company operates in the United States and Europe.

  • Revenue in USD (TTM)1.42m
  • Net income in USD-413.36k
  • Incorporated2007
  • Employees6.00
  • Location
    Vycor Medical Inc951 Broken Sound Pkwy NW Ste 320BOCA RATON 33487-3531United StatesUSA
  • Phone+1 (562) 558-2000
  • Fax+1 (631) 794-2444
  • Websitehttps://www.vycormedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Motus GI Holdings Inc319.00k-12.87m2.09m15.00--0.2396--6.56-25.61-25.610.39451.740.02571.164.7321,266.67-103.47-80.63-153.17-112.32-78.37-44.53-4,033.54-6,160.581.61-17.610.4582---46.1154.7030.81---28.25--
Dynatronics Corp35.18m-5.70m2.18m154.00--0.2685--0.0621-1.38-1.388.393.431.093.167.84228,421.30-15.46-6.02-21.69-8.3021.5227.33-14.12-4.550.6695-19.740.1955---8.41-8.81-19.84---5.11--
VirExit Technologies Inc0.00-1.80m2.28m-----------0.0932-0.1130.00-0.03670.00-------6,103.43-----------------3.66-----100.00--19.08------
Nemaura Medical Inc0.00-10.65m2.31m36.00---------0.3787-0.37870.00-0.61690.000.00--0.00-117.49-58.18---131.96-------7,384.830.0305-1.4710.81---84.71---1.85--64.14--
Tenon Medical Inc2.40m-20.35m2.34m22.00--0.8838--0.9766-16.06-16.061.641.020.21542.995.23108,954.50-182.90---227.35--19.82---849.06--1.46--0.00--332.42---168.39------
Sientra Inc90.30m-59.33m2.52m304.00------0.0279-5.45-5.438.10-2.820.59051.152.82297,036.20-38.80-45.08-163.51-76.2242.1155.37-65.71-103.790.3106-14.232.20--12.2319.90-17.26--14.01--
SINTX Technologies Inc2.49m-14.37m2.58m41.00--0.0199--1.04-19.58-19.580.90412.540.16560.628610.1860,731.71-65.81-48.62-84.49-61.3185.1849.34-397.43-1,209.111.87--0.0067--157.59---77.13--197.79--
Nuwellis Inc8.86m-22.63m2.68m59.00--0.7484--0.3022-13.45-13.454.510.56510.51471.675.28150,237.30-117.35-98.07-152.04-122.4856.2255.22-227.99-230.511.96-5.060.00--3.7612.14-55.78--4.61--
Invo Bioscience Inc1.92m-8.81m2.74m15.00--7.30--1.43-12.41-12.412.050.15060.15873.6220.38127,797.30-72.92-118.98-100.03-233.0749.4890.05-459.42-389.510.3148-9.690.8824---80.2423.85-63.68------
Vycor Medical Inc1.42m-413.36k2.88m6.00------2.02-0.013-0.01310.0421-0.09911.420.59326.53237,268.30-8.88-70.18----90.1689.31-6.25-54.920.10450.1278-----12.20-2.461.17---56.73--
Hawkeye Systems Inc0.00-1.13m3.16m44.00---------0.2072-0.20720.00-0.43460.00-------134.43-330.11-----------218.49---4.948.06------4.85------
InnerScope Hearing Technologies, Inc.334.45k-7.15m3.21m24.00------9.60-0.0153-0.01530.0002-0.00280.09553.931.71---204.11-27.82---94.5317.7958.17-2,138.50-42.130.0022-0.4232------100.59----233.50--
Pressure Biosciences Inc2.27m-29.56m3.37m15.00------1.48-1.70-1.700.1299-1.221.022.289.17151,505.30-1,074.63-643.54----6.8934.75-1,050.30-798.210.0185-0.4182-----13.64-5.0521.52---34.47--
Therapeutic Solutions International Inc83.74k-2.68m3.55m3.00--2.50--42.39-0.0009-0.00090.000030.00040.02192.022.6127,913.33-70.01-266.56-166.67--13.7668.65-3,204.77-2,778.600.0753-4.660.3665--41.66135.57-24.19------
Micron Solutions Inc17.50m-2.14m3.65m88.00--1.52--0.2086-0.7422-0.74226.070.75761.675.117.82---20.38-8.49-41.50-13.2510.0712.65-12.24-5.630.3977-3.980.7066---10.56-6.18-139.07---35.64--
Innovative Eyewear Inc1.15m-6.66m3.69m11.00--0.6632--3.20-0.6442-0.64420.10980.43030.21134.0511.33104,770.90-122.17---137.62---10.35---578.18--8.14-2,255.110.00--74.67---17.28------
Data as of Mar 28 2024. Currency figures normalised to Vycor Medical Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.